P1246211300qTeyK

1
Liver Allocation for Hepatocellular Carcinoma
Where Do We Go From Here?     OPTN/UNOS Symposium
on Liver Allocation Policy for HCC


2
Panelists
Goran B.G. Klintmalm, MD Jordi Bruix, MD
Baylor Medical Center Barcelona,
Spain   Charles M. Miller, MD Francis Yao,
MD Mount Sinai Medical Center UCSF   Gregory J.
Gores, MD Robert A. Fisher, MD Mayo
Clinic Medical College of Virginia   Ronald W.
Busuttil, MD,. PhD. Robert M. Merion,
MD UCLA
SRTR Jorge D. Reyes, MD Childrens
Hospital of Pittsurgh


3
Objectives

• Should the entry criteria be changed?
• Minimums and maximums
• Should the priority be changed?
• Drop out rates
• How to handle down staged tumors?